Literature DB >> 1286704

Sympathetic ophthalmia: visual results with modern immunosuppressive therapy.

K N Hakin1, R V Pearson, S L Lightman.   

Abstract

Sympathetic ophthalmia is a rare bilateral panuveitis that follows penetrating injury to one eye. The use of systemic corticosteroids has transformed the prognosis, and good acuity in the sympathizing eye can now be achieved. The use of immunosuppressive drugs, such as cyclosporin and azathioprine, in combination with the steroids, allows control of the intraocular inflammation at a much lower steroid dose, with concomitant reduction in the systemic side effects that accompany the use of systemic steroids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1286704     DOI: 10.1038/eye.1992.95

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

Review 1.  Sympathetic ophthalmia: an autoimmune ocular inflammatory disease.

Authors:  C C Chan; M Mochizuki
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland.

Authors:  D J Kilmartin; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

3.  [Sympathetic ophthalmia : Therapy with steroid-free immunosuppressant azathioprine].

Authors:  K Wand; M Straub; C P Lohmann; C S Mayer
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059

Review 4.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

5.  Missed perforation presenting as sympathetic ophthalmia in an adolescent Malay girl.

Authors:  Mae-Lynn Catherine Bastion; Muhaya Hj Mohamad
Journal:  BMJ Case Rep       Date:  2012-08-21

6.  Sympathetic ophthalmia in Singapore: new trends in an old disease.

Authors:  Daniel Hsien-Wen Su; Soon-Phaik Chee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-19       Impact factor: 3.117

7.  [Management of a ruptured globe].

Authors:  A Viestenz; W Schrader; M Küchle; S Walter; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

9.  Sympathetic ophthalmia: what have we learned?

Authors:  H Nida Sen; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2009-11       Impact factor: 5.258

Review 10.  [Sympathetic ophthalmia].

Authors:  U Pleyer; M Dutescu
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.